Elevated IgM against Nε-(Carboxyethyl)lysine-modified Apolipoprotein A1 peptide 141–147 in Taiwanese with Alzheimer’s disease0On April 20, 2018April 24, 2018By BSIIn User PublicationsLin, C.Y., et al. Elevated IgM against Nε-(Carboxyethyl)lysine-modified Apolipoprotein A1 peptide 141–147 in Taiwanese with Alzheimer’s disease. Clinical Biochemistry. 20/4/2018.
Leave a Reply